Nanotherapeutics for Treating Neurodegenerative Disorders

Manish K. Chourasia is the Chief Scientist in the Division of Pharmaceutics and Pharmacokinetics at CSIR Central Drug Research Institute (CDRI), Lucknow, India. He has played a significant role in advancing the field of nanoparticle-based drug delivery for breast cancer and neurodegenerative disorders, aiming to enhance the therapeutic outcome. Shubhini A. Saraf is the Director of the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, Uttar Pradesh, India. Her research interests include nanotechnology and drug targeting as well as technology policy interventions for health care. Yashwant Pathak is a Professor at Taneja College of Pharmacy at the University of South Florida, FL, United States. His area of research is nanotechnology, drug delivery systems, and nutraceuticals. He is also an Ad junct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia. Mohini Chaurasia is a Professor at Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India. Her research interests include drug delivery systems and nanotechnology applications in healthcare and biomedical field.

• 1. Concepts, types, and treatment strategies for neurodegenerative disorders2. Mechanisms of transport across the Blood: Brain Barrier3. Need for nanotherapeutics to combat neurodegenerative disorders4. Nanotechnology mediated drug delivery for addressing protein aggregation5. Nanocarriers focusing on synuclein misfolding as a therapeutic target6. Therapeutic potential of stem cells derived nanocarriers in neurological disorders7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders8. Nanocarrier-assisted delivery of drug(s)/genetic material for the targeted treatment of neurodegenerative disease9. Nanotherapeutics targeting neuroinflammation10. Nanocarriers mediated DNA repair mechanism against neurological disorders11. Nanotherapy for targeted inhibition of protein kinase R-like endoplasmic reticulum kinase: Unraveling stress-induced endoplasmic reticulum kinase12. Nanotechnological and molecular strategies for targeted modulation of microgliain neurodegenerativ ediseases13. Nanocarriers unveiling ferroptosis as a potential therapeutic target14. Proteostasis maintenance through nanotechnology: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders17. Targeting glial cells through nanotherapeutic strategies in neurological disorders18. Oligodendrocytes as an emerging therapeutic targets in neurological disorders